NO971110L - Fremgangsmåte for fremstilling av en modifisert, kollagenindusert blodplateaggregeringsinhibitor, pallidipin - Google Patents

Fremgangsmåte for fremstilling av en modifisert, kollagenindusert blodplateaggregeringsinhibitor, pallidipin

Info

Publication number
NO971110L
NO971110L NO971110A NO971110A NO971110L NO 971110 L NO971110 L NO 971110L NO 971110 A NO971110 A NO 971110A NO 971110 A NO971110 A NO 971110A NO 971110 L NO971110 L NO 971110L
Authority
NO
Norway
Prior art keywords
pallidipine
asp
platelet aggregation
amino acid
aspartic acid
Prior art date
Application number
NO971110A
Other languages
English (en)
Norwegian (no)
Other versions
NO971110D0 (no
Inventor
Christiane Noeske-Jungblut
Andreas Becker
Bernard Haendler
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO971110D0 publication Critical patent/NO971110D0/no
Publication of NO971110L publication Critical patent/NO971110L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO971110A 1994-09-12 1997-03-11 Fremgangsmåte for fremstilling av en modifisert, kollagenindusert blodplateaggregeringsinhibitor, pallidipin NO971110L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94250224 1994-09-12
PCT/EP1995/003573 WO1996008563A1 (en) 1994-09-12 1995-09-11 Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin

Publications (2)

Publication Number Publication Date
NO971110D0 NO971110D0 (no) 1997-03-11
NO971110L true NO971110L (no) 1997-05-07

Family

ID=8217517

Family Applications (1)

Application Number Title Priority Date Filing Date
NO971110A NO971110L (no) 1994-09-12 1997-03-11 Fremgangsmåte for fremstilling av en modifisert, kollagenindusert blodplateaggregeringsinhibitor, pallidipin

Country Status (22)

Country Link
US (1) US5882887A (sl)
EP (1) EP0781334A1 (sl)
JP (1) JPH10505502A (sl)
CN (1) CN1075836C (sl)
AU (1) AU701643B2 (sl)
BG (1) BG63276B1 (sl)
BR (1) BR9508910A (sl)
CA (1) CA2199719A1 (sl)
CZ (1) CZ76297A3 (sl)
FI (1) FI971013A (sl)
HU (1) HU222398B1 (sl)
IL (1) IL115272A0 (sl)
MX (1) MX9701720A (sl)
NO (1) NO971110L (sl)
NZ (1) NZ293261A (sl)
PL (1) PL184617B1 (sl)
RO (1) RO117971B1 (sl)
RU (1) RU2186110C2 (sl)
SI (1) SI9520093A (sl)
SK (1) SK29297A3 (sl)
WO (1) WO1996008563A1 (sl)
ZA (1) ZA957649B (sl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4805461B2 (ja) * 1999-03-18 2011-11-02 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング 血小板接着の阻止用タンパク質
CA2578072A1 (en) * 2004-12-28 2006-07-06 Ares Trading S.A. Compositions and methods for treating schizophrenia and related disorders
US20110034396A1 (en) * 2005-09-28 2011-02-10 Biovascular, Inc. Methods and compositions for inhibiting cell migration and treatment of inflammatory conditions
WO2007038749A2 (en) * 2005-09-28 2007-04-05 Biovascular, Inc. Methods and compositions for blocking platelet and cell adhesion, cell migration and inflammation
TWI391143B (zh) * 2005-11-04 2013-04-01 Otsuka Pharma Co Ltd 血小板凝集抑制劑組成物
WO2012172427A2 (en) * 2011-06-14 2012-12-20 National Taiwan University Peptide compounds for inhibition of platelet aggregation
FR2979346B1 (fr) 2011-08-23 2013-09-27 Univ Joseph Fourier Nanocorps anti-vcam-1
CN104428009A (zh) 2012-02-07 2015-03-18 全球生物疗法美国有限公司 核酸输送的区室化方法及其组合物和应用
NZ705899A (en) 2012-09-07 2018-08-31 Inst Nat Sante Rech Med Inhibiting peptides derived from triggering receptor expressed on myeloid cells-1 (trem-1) trem-like transcript 1 (tlt-1) and uses thereof
MX2016001667A (es) 2013-08-08 2016-11-07 Global Bio Therapeutics Inc Dispositivo de sujecion para procedimientos minimamente invasivos y usos del mismo.
FR3058143B1 (fr) 2016-10-27 2021-03-12 Univ Grenoble Alpes Nanocorps anti-tau
WO2023017494A1 (en) 2021-08-13 2023-02-16 Triovance Holding Llc A skin substitute composition and methods of producing and using the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03503596A (ja) * 1987-06-24 1991-08-15 ノボ・ノルディスク　エー／エス 蛋白質若しくはポリペプチドの調製方法、該ポリペプチドをコードするｄｎａ配列、該ｄｎａ配列およびポリペプチドを有する微生物および該ポリペプチドの薬学的製剤としての利用
EP0530937B1 (en) * 1991-09-05 1998-08-12 Schering Aktiengesellschaft Collagen-induced platelet aggregation inhibitor
US5756454A (en) * 1991-09-05 1998-05-26 Schering Aktiengesellschaft Collagen-induced platelet aggregation inhibitor
US5705362A (en) * 1992-05-25 1998-01-06 Gist-Brocades, N.V. Modified signal sequences

Also Published As

Publication number Publication date
AU3565795A (en) 1996-03-29
WO1996008563A1 (en) 1996-03-21
BG101226A (en) 1998-10-30
HU222398B1 (hu) 2003-06-28
CZ76297A3 (cs) 1998-01-14
RU2186110C2 (ru) 2002-07-27
MX9701720A (es) 1997-06-28
SK29297A3 (en) 1997-10-08
NZ293261A (en) 1998-11-25
CA2199719A1 (en) 1996-03-21
FI971013A0 (fi) 1997-03-11
FI971013A (fi) 1997-03-11
JPH10505502A (ja) 1998-06-02
CN1159828A (zh) 1997-09-17
PL184617B1 (pl) 2002-11-29
IL115272A0 (en) 1995-12-31
ZA957649B (en) 1996-04-15
EP0781334A1 (en) 1997-07-02
RO117971B1 (ro) 2002-11-29
AU701643B2 (en) 1999-02-04
HUT76972A (hu) 1998-01-28
BG63276B1 (bg) 2001-08-31
SI9520093A (en) 1997-08-31
CN1075836C (zh) 2001-12-05
NO971110D0 (no) 1997-03-11
PL319078A1 (en) 1997-07-21
US5882887A (en) 1999-03-16
BR9508910A (pt) 1997-10-28

Similar Documents

Publication Publication Date Title
George-Nascimento et al. Characterization of recombinant human epidermal growth factor produced in yeast
Steiner et al. Golgi/granule processing of peptide hormone and neuropeptide precursors: a minireview
Mutt et al. Structure of the Porcine Vasoactive Intestinal Octacosapeptide: The Amino‐Acid Sequence. Use of Kallikrein in Its Determination
CN100500853C (zh) 用于向细菌培养物上清液中分泌目的蛋白质的融合蛋白质
NO971110L (no) Fremgangsmåte for fremstilling av en modifisert, kollagenindusert blodplateaggregeringsinhibitor, pallidipin
KR880014110A (ko) 인체 프로아포지방단백질 a-i의 발현
NZ510385A (en) E. coli enterotoxin II signal peptide and a microorganism expressing a fusion protein of the MST peptide and a heterologous protein, such as human growth hormone
CA2032153A1 (fr) Application de nouveaux fragments d'adn en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant
DK1356073T3 (da) Fermenteringsfremgangsmåde til fremstilling af heterologe genprodukter i mælkesyrebakterier
CZ636081A3 (en) Process for preparing a vector for dna transfer
Rabbani et al. Recombinant human parathyroid hormone synthesized in Escherichia coli. Purification and characterization.
EP0871474A1 (en) Generation of human insulin
RU2010127232A (ru) Рекомбинантные белки эластазы и способы их получения и применения
DE69906509D1 (de) Herstellung einzelner genprodukte eines chimären fusionsproteins durch spaltung mit überall vorkommenden endoproteasen
WO2022227707A1 (zh) 一种双靶点融合蛋白的制备方法和应用
Cristina Leite Mulder et al. Critical aspects to be considered prior to large-scale production of peptides
Allen et al. Production of epidermal growth factor in Escherichia coli from a synthetic gene
ZA916171B (en) Protein structure of the plant toxin gelonin
RU97105821A (ru) Способ производства модифицированного ингибитора индуцированной коллагеном агрегации тромбоцитов паллидипина
Lane et al. The sequestration, processing and retention of honey‐bee promelittin made in amphibian oocytes
Mikhailova et al. Autolysis of bovine enteropeptidase heavy chain: evidence of fragment 118–465 involvement in trypsinogen activation
CA2198966A1 (en) Method for cleaving chimeric protein using processing enzyme
GR3023348T3 (en) Preventing endogenous aminopeptidase mediated n-terminal amino acid cleavage during expression of foreign genes in bacteria.
CN111087475B (zh) Fgf21融合蛋白及抑制其降解的方法
Takahashi et al. The amino acid sequence of ribonuclease U1, a guanine-specific ribonuclease from the fungus Ustilago sphaerogena